Consumer Information for: TOBRAMYCIN FOR INJECTION USP
Consumer Information
Information about the product including what the product is used for, dosage, warnings, proper use and side effects. This summary will not tell you everything about the product. Contact your healthcare professional if you have any questions about the product.
What the medication is used for
Tobramycin for Injection USP is an antibiotic for intravenous infusion used to treat resistant infections of the respiratory tract, blood, urinary tract and central nervous system, as well as serious skin and soft tissue infections.
Antibacterial drugs like Tobramycin for Injection USP treat only bacterial infections. They do not treat viral infections such as the common cold. Although you may feel better early in treatment, Tobramycin for Injection USP should be used exactly as directed. Misuse or overuse of Tobramycin for Injection USP could lead to the growth of bacteria that will not be killed by Tobramycin for Injection USP (resistance). This means that Tobramycin for Injection USP may not work for you in the future. Do not share your medicine.
Tobramycin for Injection USP may be indicated for the treatment of the following infections when caused by susceptible organisms: septicemia, complicated and recurrent urinary tract infections, lower respiratory infections, serious skin and soft tissue infections including burns and peritonitis and central nervous system infections caused by organisms resistant to antibiotics usually considered efficacious in these infections.
Tobramycin for Injection USP is usually active against most strains of the following organisms in vitro and in clinical infections:
- Pseudomonas aeruginosa Proteus sp. (Indole-positive and indole- negative), including Proteus mirabilis, Morganella morganii, Providencia rettgeri, and Proteus vulgaris Escherichia coli Klebsiella-Enterobacter-Serratia group Citrobacter sp. Providencia sp. Staphylococci, including Staphylococcus aureus (coagulase-positive and coagulase-negative)
What it does
Tobramycin for Injection USP is believed to interfere with the bacteria’s normal protein synthesis so that it cannot grow or function properly.
When it should not be used
If you are allergic (hypersensitive) to tobramycin or other aminoglycosides.
What the medicinal ingredient is
tobramycin sulphate
What the non-medicinal ingredients are
Sulfuric Acid and/or Sodium Hydroxide may have been added during manufacturing to adjust pH.
What dosage form it comes in
Each vial contains tobramycin sulphate equivalent to 1.2 g tobramycin.
Warnings and precautions
Serious Warnings and Precautions
Patients treated with Tobramycin for Injection USP or other aminoglycosides should be under close clinical observation because these drugs have an inherent potential for causing ototoxicity and nephrotoxicity.
Tobramycin for Injection USP and other similar aminoglycosides have been known to cause hearing and balance problems (ototoxicity) and kidney problems (nephrotoxicity). Your doctor will observe you carefully for warning signs of these events after giving you Tobramycin for Injection USP.
Before using Tobramycin for Injection USP, tell your doctor if you (or your child) have or have had:
- Drug allergies
- Hearing or balance problem
- Kidney problems
- Myasthenia gravis (a muscle condition)
- Parkinson’s Disease
Tell your doctor if you are pregnant, breastfeeding, are planning to become pregnant.
Your doctor may monitor the level of Tobramycin for Injection USP in your blood through blood tests, especially if you are taking medications.
Interactions with this medication
Tobramycin for Injection USP may interact with other medications. Tell your doctor if you (or your child) are taking any medications, especially the following:
- Aminoglycosides (e.g. amikacin, streptomycin, neomycin, kanamycin, gentamycin, paramomycin)
- Amphotericin B
- Anaesthetics
- Cephaloridin
- Cisplatin
- Diuretics (specifically potent diuretics)
- Polymyxin B
- Succinylcholine
- Tubocurarine
- Vancomycin
- Viomycin
Proper use of this medication
Tobramycin for Injection USP is for intravenous infusion only.
Usual Dose
The amount of antibiotic you (or your child) will receive will be determined by your healthcare professional. It is dependant upon a number of factors, including your age, weight, type of infection, and any pre-existing medical conditions.
You may receive Tobramycin for Injection USP several times a day over a period of 7-10 days.
Overdose
Your healthcare professional is trained to recognize the symptoms of an overdose, and deal with its symptoms.
Side effects and what to do about them
You may experience side effects from using Tobramycin for Injection USP including:
- Diarrhea
- Fever
- Headache
- Hives
- Itching or skin irritation
- Nausea
- Rash
- Reaction at the injection site
- Tiredness
- Vomiting
Tell your doctor if you notice any of the above.
Symptom / effect | Talk with your doctor or pharmacist Only if severe |
Talk with your doctor or pharmacist In all cases |
Stop taking drug and call your doctor or pharmacist |
---|---|---|---|
Uncommon | |||
Kidney problems (decreased urination) | ✔ | ✔ | |
Hearing and balance problems (loss of hearing, ringing in the ears, dizziness, loss of balance) | ✔ | ✔ | |
Anemia (symptoms include weakness, exhastion, pale skin) | ✔ | ✔ | |
Unusual respiratory difficulties (difficulty breathing) | ✔ | ✔ |
There are also other effects which can occur while you are taking tobramycin. These more rarely include kidney and respiratory difficulties. Nerve problems such as hearing, balance, or dizziness, which you may not have experienced before, can occur when you are being administered the drug or may appear weeks after taking it. It is important that you immediately advise your doctor of such events.
This is not a complete list of side effects. For any unexpected effects while taking Tobramycin for Injection, USP contact your doctor or pharmacist.
How to store
Tobramycin for Injection USP in powder form should be stored at room temperature (15 - 30 ° C).
Protect from light.
Do not use if the solution is hazy, discoloured, leaking, or contains particulate matter (precipitate)
Reporting side effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
- Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
- Calling toll-free at 1-866-234-2345
Note: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.
More information
This document plus the full product monograph, prepared for health professionals can be found at: http://www.sterimaxinc.com or by contacting the sponsor, SteriMax Inc., at: 1-800-881-3550
This leaflet was prepared by SteriMax Inc.
Last revised: August 15, 2018
Related Drug Products
Product name | DIN | Company name | Active ingredient(s) & strength |
---|---|---|---|
APO-BACLOFEN | 02139332 | APOTEX INC | BACLOFEN 10 MG |
APO-BACLOFEN | 02139391 | APOTEX INC | BACLOFEN 20 MG |